Literature DB >> 6693168

Oral toxicities of Clostridium botulinum type A and B toxins from different strains.

I Ohishi.   

Abstract

The production and the oral toxicity for mice of Clostridium botulinum type A and B toxins of different strains were studied. All five type B strains produced both 16S (large or L) and 12S (medium or M) toxins, although the relative amounts varied with the strains. The culture supernatant of type B Okra strain was the most potent in oral toxicity. The L toxin of this culture was about 700 times more toxic in feeding tests with mice than the L toxin from type B strain NH-2, whereas the M toxins of the two strains had the same oral toxicity. These results indicate that the oral toxicity of type B toxin varies with the culture strain. Oral toxicities of L toxin produced by type A strains 62A and 97 were comparable but were 10 times higher than those of their M toxins. Hybrids of toxic and nontoxic components separated from L toxins of type B strains Okra and NH-2 revealed that the high oral toxicity of the B-L toxin of strain Okra is attributable not to the toxic but to the nontoxic component of the toxin. The present study suggests that the 16S molecular-sized toxin elaborated by a certain strain of C. botulinum type B is implicated in the high fatality rate in type B human botulism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693168      PMCID: PMC264322          DOI: 10.1128/iai.43.2.487-490.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.

Authors:  S Miyazaki; M Iwasaki; G Sakaguchi
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Intestinal absorption of botulinum toxins of different molecular sizes in rats.

Authors:  S Sugii; I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

4.  Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.

Authors:  I Ohishi; G Sakaguchi
Journal:  Jpn J Med Sci Biol       Date:  1977-08

5.  Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum.

Authors:  D A Boroff; U Fleck
Journal:  J Bacteriol       Date:  1966-11       Impact factor: 3.490

6.  Purification and some properties of progenitor toxins of Clostridium botulinum type B.

Authors:  S Kozaki; S Sakaguchi; G Sakaguchi
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

7.  Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes.

Authors:  I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

8.  Molecular construction of Clostridium botulinum type A toxins.

Authors:  S Sugii; G Sakaguchi
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

9.  Clinical features of types A and B food-borne botulism.

Authors:  J M Hughes; J R Blumenthal; M H Merson; G L Lombard; V R Dowell; E J Gangarosa
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

10.  Purification of Clostridium botuliunum type F progenitor toxin.

Authors:  I Oishi; G Sakaguchi
Journal:  Appl Microbiol       Date:  1974-12
View more
  12 in total

1.  Inhibiting oral intoxication of botulinum neurotoxin A complex by carbohydrate receptor mimics.

Authors:  Kwangkook Lee; Kwok-Ho Lam; Anna-Magdalena Kruel; Stefan Mahrhold; Kay Perry; Luisa W Cheng; Andreas Rummel; Rongsheng Jin
Journal:  Toxicon       Date:  2015-08-10       Impact factor: 3.033

Review 2.  Properties and use of botulinum toxin and other microbial neurotoxins in medicine.

Authors:  E J Schantz; E A Johnson
Journal:  Microbiol Rev       Date:  1992-03

3.  Pure botulinum neurotoxin is absorbed from the stomach and small intestine and produces peripheral neuromuscular blockade.

Authors:  A B Maksymowych; M Reinhard; C J Malizio; M C Goodnough; E A Johnson; L L Simpson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  High-resolution crystal structure of HA33 of botulinum neurotoxin type B progenitor toxin complex.

Authors:  Kwangkook Lee; Kwok-Ho Lam; Anna Magdalena Kruel; Kay Perry; Andreas Rummel; Rongsheng Jin
Journal:  Biochem Biophys Res Commun       Date:  2014-03-12       Impact factor: 3.575

5.  Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.

Authors:  K Tsuzuki; N Yokosawa; B Syuto; I Ohishi; N Fujii; K Kimura; K Oguma
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

6.  Comparison of oral toxicological properties of botulinum neurotoxin serotypes A and B.

Authors:  Luisa W Cheng; Thomas D Henderson
Journal:  Toxicon       Date:  2011-05-11       Impact factor: 3.033

Review 7.  Architecture of the botulinum neurotoxin complex: a molecular machine for protection and delivery.

Authors:  Kwok-Ho Lam; Rongsheng Jin
Journal:  Curr Opin Struct Biol       Date:  2015-04-15       Impact factor: 6.809

8.  Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex.

Authors:  Kwangkook Lee; Xiaofen Zhong; Shenyan Gu; Anna Magdalena Kruel; Martin B Dorner; Kay Perry; Andreas Rummel; Min Dong; Rongsheng Jin
Journal:  Science       Date:  2014-06-20       Impact factor: 47.728

9.  Purification and characterization of nontoxic protein complex from serotype D 4947 botulinum toxin complex.

Authors:  Keita Miyata; Yoshimasa Sagane; Ken Inui; Shin-Ichiro Miyashita; Tomonori Suzuki; Keiji Oguma; Tohru Ohyama; Koichi Niwa; Toshihiro Watanabe
Journal:  Protein J       Date:  2012-06       Impact factor: 2.371

10.  Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity.

Authors:  Kwangkook Lee; Shenyan Gu; Lei Jin; Thi Tuc Nghi Le; Luisa W Cheng; Jasmin Strotmeier; Anna Magdalena Kruel; Guorui Yao; Kay Perry; Andreas Rummel; Rongsheng Jin
Journal:  PLoS Pathog       Date:  2013-10-10       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.